Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

3.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model.

Molecular therapy. Nucleic acids·2026
Same author

Iterative immunoprecipitation and phage pre-wash dramatically improve epitope-resolved serology by VirScan.

Frontiers in virology (Lausanne, Switzerland)·2026
Same author

Proximity proteomics reveals a role for IFI16 during human coronavirus infection.

bioRxiv : the preprint server for biology·2026
Same author

PABPC1 Modulates Immunoglobulin pre-mRNA Alternative Polyadenylation.

bioRxiv : the preprint server for biology·2026
Same author

Electromechanical Dynamics and Myogenic Responses in Cerebral Smooth Muscle Cells and Capillary Pericytes.

bioRxiv : the preprint server for biology·2026
Same author

Structural insights into single-pass transmembrane receptor GC-A activation by distinct antihypertensive antibodies.

Nature communications·2026
Same journal

Diagnostic value of miR-126-5p in sepsis-induced acute kidney injury and its molecular mechanism via CASP3.

Shock (Augusta, Ga.)·2026
Same journal

Temporal changes of the von Willebrand factor-ADAMTS13 axis during the first 24 hours in major trauma patients with isolated brain injury and without brain injury: a prospective observational study.

Shock (Augusta, Ga.)·2026
Same journal

Epinephrine nebulization delays need for life-saving intervention following smoke inhalation in ovine model.

Shock (Augusta, Ga.)·2026
Same journal

Sodium-Glucose Cotransporter 2 Inhibitors as Discharge Medications in Survivors of Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Shock (Augusta, Ga.)·2026
Same journal

Dynamic Temperature Modeling Predicts Mortality in Murine Sepsis.

Shock (Augusta, Ga.)·2026
Same journal

Changes of Intestinal Aquaporins after Experimental Polytrauma and Hemorrhagic Shock: Erratum.

Shock (Augusta, Ga.)·2026
See all related articles

Related Experiment Video

Updated: May 30, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.8K

ENDOTHELIAL-SPECIFIC KNOCKOUT OF THE SCRAMBLASE TMEM16F IMPAIRS IN VIVO CLOT FORMATION.

Grace Bonson1, Aaron R Lambert1, Adrian M Sackheim1

  • 1Department of Emergency Medicine, University of Vermont, Burlington, Vermont.

Shock (Augusta, Ga.)
|January 28, 2025
PubMed
Summary
This summary is machine-generated.

Endothelial TMEM16F is crucial for normal hemostasis. Mice lacking TMEM16F in endothelial cells showed prolonged bleeding and reduced clot formation, indicating its role in preventing bleeding disorders.

Keywords:
Mouseblood vesselscoagulopathyendotheliumhemostasisphosphatidylserinescramblasethrombosis

More Related Videos

Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model
09:36

Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model

Published on: August 29, 2012

18.9K
Whole-Mount In Situ Hybridization in Zebrafish Embryos and Tube Formation Assay in iPSC-ECs to Study the Role of Endoglin in Vascular Development
08:27

Whole-Mount In Situ Hybridization in Zebrafish Embryos and Tube Formation Assay in iPSC-ECs to Study the Role of Endoglin in Vascular Development

Published on: May 28, 2020

7.8K

Related Experiment Videos

Last Updated: May 30, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.8K
Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model
09:36

Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model

Published on: August 29, 2012

18.9K
Whole-Mount In Situ Hybridization in Zebrafish Embryos and Tube Formation Assay in iPSC-ECs to Study the Role of Endoglin in Vascular Development
08:27

Whole-Mount In Situ Hybridization in Zebrafish Embryos and Tube Formation Assay in iPSC-ECs to Study the Role of Endoglin in Vascular Development

Published on: May 28, 2020

7.8K

Area of Science:

  • Vascular Biology
  • Hemostasis and Thrombosis
  • Cellular Physiology

Background:

  • Loss of phospholipid scramblase (PLS) TMEM16F function causes Scott syndrome, a bleeding disorder linked to platelet dysfunction.
  • The specific role of TMEM16F in endothelial cells remains largely unexplored.

Purpose of the Study:

  • To investigate the contribution of endothelial TMEM16F to hemostasis.
  • To test if TMEM16F in endothelial cells is essential for regulating bleeding time and venous clotting.

Main Methods:

  • Pharmacological inhibition of TMEM16F in cultured endothelial cells exposed to histones, assessing calcium signaling and phosphatidylserine translocation.
  • Generation of endothelial-specific TMEM16F knockout (ECKO) mice using a tamoxifen-inducible cre-lox system.
  • Evaluation of hemostasis via tail bleeding time and inferior vena cava (IVC) stenosis-induced thrombus formation.
  • Assessment of plasma coagulation and endothelial-dependent vasodilation.

Main Results:

  • Inhibition of TMEM16F prevented pathological calcium signals and phosphatidylserine translocation in endothelial cells.
  • TMEM16F ECKO mice exhibited significantly prolonged bleeding times and reduced IVC thrombus size compared to controls.
  • TMEM16F ablation did not affect prothrombin time or endothelial vasodilation.

Conclusions:

  • Endothelial TMEM16F plays a critical role in maintaining normal hemostasis.
  • Ablation of TMEM16F specifically in endothelial cells results in a coagulopathic phenotype.
  • These findings suggest TMEM16F's involvement in trauma-induced coagulopathy due to its role in endothelial calcium signaling.